Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cynata Therapeutics Limited CYYNF

Full chart Compare
Set alert

Price alert · CYYNF

All alert types
0.01 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.11 Day range 0.11
0.0014 52-week range 0.2225
YTD
-95.20%
1 year
-93.90%

Financial health

Altman Z-Score

-127.17 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.1×
FY 2017: -10.5×FY 2018: -27.4×FY 2019: -16.0×FY 2020: -20.0×FY 2021: -10.5×FY 2022: -11.4×FY 2023: -3.7×FY 2024: -5.3×FY 2025: -2.7×FY 2026: -0.1×
FY 2017 5y median -3.7× FY 2026
P/S 0.8×
FY 2017: 27.3×FY 2018: 91.0×FY 2019: 103×FY 2020: 10.4×FY 2021: 52.3×FY 2022: 8.0×FY 2023: 31.6×FY 2024: 22.1×FY 2025: 13.2×FY 2026: 0.8×
FY 2017 5y median 13.2× FY 2026
P/B -3.5×
FY 2017: 3.4×FY 2018: 8.1×FY 2019: 12.3×FY 2020: 4.3×FY 2021: 2.8×FY 2022: 2.6×FY 2023: 3.1×FY 2024: 7.1×FY 2025: 4.2×FY 2026: -3.5×
FY 2017 5y median 3.1× FY 2026
P/FCF -0.2×
FY 2017: -11.8×FY 2018: -30.8×FY 2019: -20.0×FY 2020: -21.4×FY 2021: -15.7×FY 2022: -18.9×FY 2023: -3.7×FY 2024: -5.1×FY 2025: -2.8×FY 2026: -0.2×
FY 2017 5y median -3.7× FY 2026
EV/EBITDA -0.1×
FY 2017: -6.2×FY 2018: -19.3×FY 2019: -13.1×FY 2020: -5.8×FY 2021: -6.1×FY 2022: -2.8×FY 2023: -2.2×FY 2024: -4.5×FY 2025: -2.1×FY 2026: -0.1×
FY 2017 5y median -2.2× FY 2026
EV/Sales 0.3×
FY 2017: 21.4×FY 2018: 82.1×FY 2019: 98.2×FY 2020: 8.4×FY 2021: 35.0×FY 2022: 4.9×FY 2023: 21.8×FY 2024: 19.4×FY 2025: 10.5×FY 2026: 0.3×
FY 2017 5y median 10.5× FY 2026
FCF Yield -492.3%
FY 2017: -8.5%FY 2018: -3.2%FY 2019: -5.0%FY 2020: -4.7%FY 2021: -6.4%FY 2022: -5.3%FY 2023: -27.3%FY 2024: -19.4%FY 2025: -35.2%FY 2026: -492.3%
FY 2017 5y median -27.3% FY 2026

Profitability

Gross Margin 100.0%
FY 2017: 84.0%FY 2018: 79.6%FY 2019: 78.6%FY 2020: 96.0%FY 2021: 81.9%FY 2022: 96.4%FY 2023: 83.1%FY 2024: 87.9%FY 2025: 100.0%FY 2026: 100.0%
FY 2017 5y median 96.4% FY 2026
Operating Margin -354.5%
FY 2017: -362.1%FY 2018: -445.8%FY 2019: -768.9%FY 2020: -149.9%FY 2021: -375.6%FY 2022: -55.2%FY 2023: -785.8%FY 2024: -380.4%FY 2025: -430.9%FY 2026: -354.5%
FY 2017 5y median -380.4% FY 2026
Net Margin -560.0%
FY 2017: -260.4%FY 2018: -332.0%FY 2019: -647.4%FY 2020: -51.9%FY 2021: -497.4%FY 2022: -70.1%FY 2023: -863.0%FY 2024: -420.8%FY 2025: -498.1%FY 2026: -560.0%
FY 2017 5y median -498.1% FY 2026
ROE 2434.7%
FY 2017: -32.8%FY 2018: -29.7%FY 2019: -77.2%FY 2020: -21.7%FY 2021: -27.1%FY 2022: -22.7%FY 2023: -85.3%FY 2024: -135.0%FY 2025: -157.0%FY 2026: 2434.7%
FY 2017 5y median -85.3% FY 2026
ROIC 1541.3%
FY 2017: -44.7%FY 2018: -38.6%FY 2019: -88.9%FY 2020: -62.6%FY 2021: -20.5%FY 2022: -17.9%FY 2023: -77.7%FY 2024: -98.6%FY 2025: -135.8%FY 2026: 1541.3%
FY 2017 5y median -77.7% FY 2026
ROA -708.6%
FY 2017: -31.9%FY 2018: -28.3%FY 2019: -69.2%FY 2020: -20.8%FY 2021: -25.7%FY 2022: -20.5%FY 2023: -75.2%FY 2024: -116.2%FY 2025: -130.5%FY 2026: -708.6%
FY 2017 5y median -116.2% FY 2026

Growth (YoY)

Revenue -9.2%
FY 2017: 59.0%FY 2018: -21.4%FY 2019: -4.8%FY 2020: 435.8%FY 2021: -77.9%FY 2022: 402.6%FY 2023: -78.7%FY 2024: 40.0%FY 2025: -18.6%FY 2026: -9.2%
FY 2017 FY 2026
Operating Income 25.3%
FY 2017: -2.4%FY 2018: 3.2%FY 2019: -64.1%FY 2020: -4.5%FY 2021: 44.8%FY 2022: 26.2%FY 2023: -203.2%FY 2024: 32.2%FY 2025: 7.8%FY 2026: 25.3%
FY 2017 FY 2026
EPS (diluted) 14.6%
FY 2017: 16.6%FY 2018: 11.5%FY 2019: -68.3%FY 2020: 58.9%FY 2021: -70.0%FY 2022: 35.6%FY 2023: -158.9%FY 2024: 44.9%FY 2025: 15.5%FY 2026: 14.6%
FY 2017 FY 2026
Free Cash Flow 23.2%
FY 2017: 6.4%FY 2018: -0.3%FY 2019: -66.4%FY 2020: 49.9%FY 2021: -52.4%FY 2022: 36.1%FY 2023: -333.0%FY 2024: 30.3%FY 2025: 11.9%FY 2026: 23.2%
FY 2017 FY 2026

Financial Health

Current Ratio 0.6×
FY 2017: 26.8×FY 2018: 16.9×FY 2019: 5.7×FY 2020: 20.1×FY 2021: 17.0×FY 2022: 9.3×FY 2023: 7.5×FY 2024: 5.6×FY 2025: 4.4×FY 2026: 0.6×
FY 2017 5y median 5.6× FY 2026
Quick Ratio 0.6×
FY 2017: 26.8×FY 2018: 17.3×FY 2019: 5.7×FY 2020: 20.1×FY 2021: 17.0×FY 2022: 9.3×FY 2023: 7.5×FY 2024: 5.6×FY 2025: 4.4×FY 2026: 0.6×
FY 2017 5y median 5.6× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.1×
FY 2017: 1.7×FY 2018: 2.1×FY 2019: 0.7×FY 2020: 1.3×FY 2021: 3.0×FY 2022: 1.8×FY 2023: 1.0×FY 2024: 0.6×FY 2025: 0.5×FY 2026: 0.1×
FY 2017 5y median 0.6× FY 2026
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-06-30